Gitego, Nadege
Agianian, Bogos
Mak, Oi Wei
Kumar MV, Vasantha
Cheng, Emily H. http://orcid.org/0000-0002-3595-2648
Gavathiotis, Evripidis http://orcid.org/0000-0001-6319-8331
Article History
Received: 17 January 2023
Accepted: 29 November 2023
First Online: 16 December 2023
Competing interests
: E.G. has received compensation for consulting and serving on scientific advisory boards, and has equity ownership from BAKX Therapeutics, Life Biosciences, Stelexis Therapeutics; and has consulted for Boehringer Ingelheim and Guidepoint. All E.G. consulting activities are outside of the submitted work. The other authors declare no competing interests.